Wendy Stock to Antigens, CD19
This is a "connection" page, showing publications Wendy Stock has written about Antigens, CD19.
Connection Strength
0.098
-
Sequencing antigen-targeting antibodies and cellular therapies in adults with relapsed/refractory B-cell acute lymphoblastic leukemia. Am J Hematol. 2023 04; 98(4):666-680.
Score: 0.054
-
Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia. Blood Adv. 2020 02 11; 4(3):449-457.
Score: 0.044